NEW YORK , May 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=81712&from=4 CLASS PERIOD: February 23, 2022 to February 28, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company deceived the investing public, including plaintiff; (ii) cause the market price of Inari common stock to trade above its true value; and (iii) cause plaintiff as well as other class members to purchase or otherwise acquire Inari common stock at artificially inflated prices that did not reflect the stock's true value during the class period.
In furtherance of their unlawful scheme, plan, or course of conduct, defendants took the actions alleged herein. DEADLINE: July 12, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.
com/securities/inari-medical-inc-loss-submission-form/?id=81712&from=4 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of NARI during the ti.
